Estee Gold Feet Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Estee Gold Feet Tbk. trades at Rp1,735 (market cap 4.42T, 44.7K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp244 (market cap 167.37B, 50.8K 24h volume). The key difference: Estee Gold Feet Tbk. is far larger — about 26.4× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (50.8K versus 44.7K). Which is the better fit depends on your goals.
| EURO | OBAT | |
|---|---|---|
Market Cap | 4.42T | 167.37B |
Volume | 44.7K | 50.8K |
Lot | 447 | 508 |
Turnover | 77.8M | 12.5M |
Average Price | 1,740.51 | 246.09 |
Value | 77.8M | 12.5M |
Indicative Equilibrium Price | — | 246 |
Indicative Equilibrium Volume | — | 2.4K |
Trailing returns across standard periods
Latest headlines on both assets
PT Estee Gold Feet Tbk (Company) was established by Notarial Deed No. 32 dated January 21, 1980 from Abdoel Sjoekoer, S.H., Notary in Jakarta. The Company started its commercial operations in 1986. The Company is controlled by its immediate parent company, PT Timmsvale, a company domiciled in Indonesia. The ultimate beneficial owners of the Company are Johansen Ngian.
Read more on EURO →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →